RecallRadar

FDA Drug recall D-1616-2014

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, In…

On 2014-10-08 the FDA classified a Class II recall of Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, In… by Actavis Laboratories Fl, citing failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1616-2014
ClassificationClass II
Statusterminated
Initiated2014-04-24
Published2014-10-08
Last updated2026-09-13 11:51 UTC
CompanyActavis Laboratories Fl
DistributionUS

Product

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.

Reason

Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.

Identifiers

upc305910398606
ndc0591-0397-60
ndc0591-0397-19
ndc0591-0398-60
code_infoLot #: 605956A, 605958A, Exp. 9/30/2014; 644678M, Exp. 10/31/2014; 661841A, Exp. 11/30/2014; 717469A, Exp 2/28/2015

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1616-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.